Atlas Trials

Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Clinical trial NCT02500043 · COMPLETED

Trial details

NCT number
NCT02500043
Sponsor
Taiho Oncology, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Refractory Metastatic Gastric Cancer
Start date
2016-02-24
Primary completion
2018-04-30
Enrollment
507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.